Aspiriant LLC’s iShares Core Moderate Allocation ETF AOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Buy
49,669
+4,451
+10% +$215K 0.07% 98
2025
Q4
$2.16M Hold
45,218
0.06% 103
2025
Q3
$2.15M Buy
45,218
+6,431
+17% +$299K 0.07% 96
2025
Q2
$1.79M Buy
38,787
+9,158
+31% +$405K 0.06% 110
2025
Q1
$1.3M Hold
29,629
0.05% 124
2024
Q4
$1.29M Sell
29,629
-1,498
-5% -$66.4K 0.05% 126
2024
Q3
$1.4M Hold
31,127
0.05% 117
2024
Q2
$1.34M Sell
31,127
-26,999
-46% -$1.14M 0.05% 118
2024
Q1
$2.49M Sell
58,126
-3,844
-6% -$161K 0.1% 88
2023
Q4
$2.57M Buy
61,970
+237
+0.4% +$9.39K 0.12% 79
2023
Q3
$2.4M Hold
61,733
0.12% 80
2023
Q2
$2.49M Sell
61,733
-509
-0.8% -$20.3K 0.13% 80
2023
Q1
$2.48M Sell
62,242
-2,460
-4% -$96.7K 0.13% 79
2022
Q4
$2.46M Sell
64,702
-18,369
-22% -$696K 0.13% 75
2022
Q3
$3.04M Buy
83,071
+8,560
+11% +$335K 0.15% 63
2022
Q2
$2.9M Sell
74,511
-107,202
-59% -$4.33M 0.14% 64
2022
Q1
$7.81M Buy
181,713
+8,058
+5% +$351K 0.43% 36
2021
Q4
$7.9M Sell
173,655
-13,731
-7% -$623K 0.42% 32
2021
Q3
$8.38M Buy
187,386
+4,862
+3% +$221K 0.49% 27
2021
Q2
$8.22M Hold
182,524
0.47% 27
2021
Q1
$7.95M Sell
182,524
-462
-0.3% -$20.1K 0.51% 27
2020
Q4
$7.9M Sell
182,986
-8,374
-4% -$353K 0.54% 25
2020
Q3
$7.86M Sell
191,360
-9,553
-5% -$392K 0.61% 26
2020
Q2
$8.01M Buy
200,913
+184,588
+1,131% +$7.12M 0.74% 23
2020
Q1
$600K Buy
+16,325
New +$639K 0.06% 111

Other funds holding AOM

Aspiriant LLC's AOM Position: Q1 2026 in Review

Aspiriant LLC increased its iShares Core Moderate Allocation ETF (AOM) stake by 9.8% in Q1 2026, buying an estimated $215K and bringing the position to 49,669 shares worth $2.35M. The position accounts for 0.07% of the portfolio, ranked #98.

Aspiriant LLC first reported a position in AOM in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.38M in Q3 2021. 292 funds tracked by Wall St. Rank hold AOM as of Q1 2026.

  • Aspiriant LLC held 49,669 shares of iShares Core Moderate Allocation ETF worth $2.35M as of Q1 2026.
  • Aspiriant LLC bought 4,451 iShares Core Moderate Allocation ETF shares in Q1 2026, an estimated $215K.
  • iShares Core Moderate Allocation ETF made up 0.07% of Aspiriant LLC's portfolio in Q1 2026, its #98 holding.
  • Aspiriant LLC first reported a position in iShares Core Moderate Allocation ETF in Q1 2020 and has held it in 25 quarters since.
  • Aspiriant LLC's iShares Core Moderate Allocation ETF position peaked at $8.38M in Q3 2021.
  • 292 funds tracked by Wall St. Rank held iShares Core Moderate Allocation ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.